Therapeutics News and Research

RSS
Unemployed nurses are switching to RN health coach careers

Unemployed nurses are switching to RN health coach careers

ImmunoCellular Therapeutics files a provisional patent application

ImmunoCellular Therapeutics files a provisional patent application

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Cumberland Pharmaceuticals publishes data on its Phase III intravenous ibuprofen study

Rexahn Pharmaceuticals announces positive results from Phase IIa Serdaxin clinical study

Rexahn Pharmaceuticals announces positive results from Phase IIa Serdaxin clinical study

Hydra Biosciences and Cubist Pharmaceuticals join to develop novel ion channel drugs

Hydra Biosciences and Cubist Pharmaceuticals join to develop novel ion channel drugs

Health Canada issues Notice of Non-Compliance to Winston Laboratories for CIVANEX

Health Canada issues Notice of Non-Compliance to Winston Laboratories for CIVANEX

Jennerex' JX-594 granted European Orphan Drug Designation for the treatment of hepatocellular carcinoma

Jennerex' JX-594 granted European Orphan Drug Designation for the treatment of hepatocellular carcinoma

Amylin Pharmaceuticals to present new data from its obesity program at Obesity 2009

Amylin Pharmaceuticals to present new data from its obesity program at Obesity 2009

Positive results from Transave's Phase II ARIKACE clinical trials

Positive results from Transave's Phase II ARIKACE clinical trials

Alnara Pharmaceuticals’ announces results of its international Phase 3 study of liprotamase

Alnara Pharmaceuticals’ announces results of its international Phase 3 study of liprotamase

Lux Biosciences raises $50 million through Series B venture financing

Lux Biosciences raises $50 million through Series B venture financing

NCCN Clinical Practice Guidelines in Oncology updated to include pralatrexate drug

NCCN Clinical Practice Guidelines in Oncology updated to include pralatrexate drug

Angiochem announces results of Phase 1 /2 clinical trials of ANG1005

Angiochem announces results of Phase 1 /2 clinical trials of ANG1005

Cardium Therapeutics reports positive findings from Excellarate Phase 1/2 clinical study

Cardium Therapeutics reports positive findings from Excellarate Phase 1/2 clinical study

Fate Therapeutics announces human iPSC generation using a combination of small molecules

Fate Therapeutics announces human iPSC generation using a combination of small molecules

Cancer Therapeutics and Nanotherapies sign letter of intent

Cancer Therapeutics and Nanotherapies sign letter of intent

Overview of innovative technology for treating ischemic and autoimmune disorders

Overview of innovative technology for treating ischemic and autoimmune disorders

Prometheus Laboratories introduces three new cancer diagnostic products

Prometheus Laboratories introduces three new cancer diagnostic products

Baxter International announces financial results for third quarter 2009; updates full-year financial outlook

Baxter International announces financial results for third quarter 2009; updates full-year financial outlook

Inspire to present its denufosol tetrasodium cystic fibrosis program data at the 23rd NACFC

Inspire to present its denufosol tetrasodium cystic fibrosis program data at the 23rd NACFC